Abstract: The present invention relates to a yogurt product that is frozen wherein the yogurt product comprising 50-100% fermented yogurt mix, preferably 80-100%, more preferably 90-100% fermented yogurt mix, and the degree of overrun of the mix is between 20 to 150% by volume, preferably 30-60%. The present invention also relates to a method of preparing such a product.

Abstract: A range of infant food products wherein each product in the range includes minimal levels of undesired by-products produced during processing as indicated by less than about 15 micrograms furan per kg food product. Methods of production and use thereof are also disclosed.

Abstract: Compositions include one or more unsaturated fatty acids and one or more nitric oxide releasing compounds. Methods for using such compositions can enhance cognitive function, reduce or prevent a decline of social interaction, reduce or prevent age-related behavioral changes, increase trainability, maintain optimal brain function, facilitate learning and memory, reduce memory loss, retard brain aging, prevent or treat strokes, and/or prevent or treat dementia in an animal. Preferably, the compositions are food compositions useful for enhancing cognitive function in humans and companion animals.

Abstract: A machine for preparing a cooled food product includes a receiving seat, for accommodating an essentially cup-shaped container, including a heat exchange element having a heat exchange contact surface arranged to be in contact with an outer surface of a side wall of the container when the container is placed in the machine, and a stirring unit connectable to a stirring member and arranged for driving the stirring member according to a combination of movements, wherein at least one of the combination of movements has a component directed towards the interior of the container when placed in the receiving seat. Also disclosed is a system including the machine, a container, and a method of preparation.

Abstract: The present invention is directed to a process for producing a water, juice, and/or milk-based ready-to-drink jellified product comprising at least two separate homogeneous gel masses, wherein adjacent separate gel masses have different gel strengths, characterized in that it comprises the steps of in order: (i) separately preparing at least two liquefied gel compositions, each comprising an aqueous, and/or juicy, and/or dairy base, mixed with carrageenan and galactomannan, (ii) separately preheating each of the compositions, (iii) separately mixing each of the liquefied gel compositions, (iv) separately cooling down each of the liquefied gel compositions, while keeping a constant agitation of the mass of each of the liquefied gel compositions, (vi) sequentially dosing each of the liquefied gel compositions into a container.

Abstract: A device (1) handles selectively a first capsule (2a) having a first flange (2a?) and a second capsule (2b) having a second flange (2b?) greater than the first flange (2a?). The device comprises: a first part (10) and a second part (20) that are relatively movable from a transfer position for inserting and/or removing such capsule (2a, 2b) to an extraction position for extracting such capsule (2a, 2b); and a third part (30) for guiding such capsule (2a, 2b) to inbetween the first and second parts (10, 20) when in the transfer position. The third part (30) has: a first portion (31a) for engaging with and guiding the first flange (2a?) of the first capsule (2a); and a second portion (31b) for engaging with and guiding the second flange (2b?) of the second capsule (2b).

Abstract: A food or beverage capsule (200), comprises: •a capsule body (201) comprising a cavity (202) and an open end (204) in communication with the cavity (202); •an injection wall (205) disposed upon the open end (204) so as to enclose the cavity (202), the injection wall (205) thereby comprising an interior side (206) facing the cavity (202); and •a quantity of a food or beverage ingredient disposed within the cavity (202). The capsule (200) further comprises a sealing membrane (207) fabricated from a flexible material and disposed upon the interior side (206) of the injection wall (205), the sealing membrane (207) being attached to the interior side (206) of the injection wall (205) over at least one fixed region (208) of the sealing membrane (207), at least one free region (209) of the sealing membrane (207) extending freely from an edge of said at least one fixed region (208).

Abstract: An infant formula container is provided with a particular lid having transparent, translucent and non-transparent/translucent parts. The container has a compartment intended to receive an object. The compartment has a bottom wall having a light reflective surface. The container of the invention provides for enhanced visibility through the lid such as to render the object in the compartment identifiable but not fully visible.

Abstract: Device for preparing a liquid beverage from a cartridge, comprising a supply unit (2) for supplying injection fluid to the cartridge (10), a cartridge holder (6) configured to accept and support a cartridge; the said cartridge holder being detachable from the device and complementary insertion means (7) are configured to allow the cartridge holder to be inserted from its detached position into the supply unit (2). The injection means (5) are provided and form part of the supply unit. The injection means are able to move into engagement with the cartridge and relative to the injection unit. Sealing means (16) are also provided in association with the injection means in order to provide sealing locally between the said injection means and the cartridge.

Abstract: The present invention relates generally to the field of nutrition and health. In particular, the present invention relates to a new biomarker, its use and a method that allows it to diagnose the likelihood to resist diet induced weight gain, and/or to be susceptible to a diet induced weight gain. For example, the biomarker may be trimethylamine-N-oxide.

Abstract: This invention relates to a preparation comprising a probiotic bacterial strain and a prebiotic mixture comprising 5-70 wt % of at least one N-acetylated oligosaccharide selected from the group consisting of Ga1NAc?1-3Ga1?1-4G1c, Ga1?1-6Ga1Nac?1-3Ga1?1-4G1c and combinations thereof, 20-95 wt % of at least one neutral oligosaccharide selected from the group consisting of Gal?1-6Gal, Gal?1-6Gal?1-4Glc, Gal?1-6Gal?1-6Glc, Gal?1-3Gal?1-3Glc, Gal?1-3Gal?1-4Glc, Gal?1-6Gal?1-6Gal?1-4Glc, Gal?1-6Gal?1-3Gal?1-4Glc, Gal?1-3Gal?1-6Gal?1-4Glc, Gal?1-3Gal?1-3Gal?1-4Glc and combinations thereof and 2-50 wt % of at least one sialylated oligosaccharide selected from the group consisting of NeuAc?2-3Gal?1-4Glc, NeuAc?2-6Ga1?1-4G1c and combinations thereof. The invention extends to food products comprising said preparation and to the use of the preparation in the prevention and treatment of infections.

Abstract: The invention relates to newly identified peptides of that are capable of inducing tolerance to cow's milk, especially to ?-lactoglobulin. The peptides may be administered to mammals, especially to young infants who are at risk of allergy to cow's milk proteins, to induce oral tolerance to cow's milk; they may also be administered to children or adults who are allergic to cow's milk to allow “desensitization” towards the allergenic milk proteins, especially ?-lactoglobulin, to occur. The peptides may also be used to induce tolerance to goat's and buffalo's milk proteins, especially ?-lactoglobulin. The peptides are capable of modulating the mammalian immune response to allergens.

Abstract: A system comprises a capsule (30) with a wall and a capsule extraction unit (10,10?, 20). The extraction unit has a capsule holder (20) for holding the capsule and an opener (10) with a cutting edge (151) for forming an opening (37,38) in the capsule wall (32,33) by cutting the wall. The opener (10,10?) further comprises a ram (152) that recesses a portion (39) of the capsule wall (32,33) adjacent to the opening (37,38) after formation of the opening by cutting the wall (32,33) by the cutting edge (151).

Abstract: Compositions comprise an amount of cinnamaldehyde that is orally tolerable, thus avoiding an unpleasant mouth feeling, and also tolerable in the gastrointestinal tract. The amount of cinnamaldehyde is supplemented by zinc, and the combination is effective to increase at least one of energy expenditure, sympathetic nervous system activity, or fat oxidation, relative to a composition lacking cinnamaldehyde and zinc but otherwise identical. The composition comprising the combination of cinnamaldehyde and zinc can be used in a method to support weight managementor promote weight loss, a method for preventing obesity or overweight, and a method for treating obesity or overweight. In an embodiment, the composition comprising cinnamaldehydeis administered to a human. The composition comprising cinnamaldehyde may be a medicament, a food product or a supplement. The composition can improve one or more of insulin sensitivity, glucose tolerance, cognitive performance, cognition, mood or memory.

Abstract: The present invention provides methods for personalized therapeutic management of a disease in order to optimize therapy and/or monitor therapeutic efficacy. In particular, the present invention comprises measuring an array of one or a plurality of biomarkers at a plurality of time points over the course of therapy with a therapeutic agent to determine a mucosal healing index for selecting therapy, optimizing therapy, reducing toxicity, and/or monitoring the efficacy of therapeutic treatment. In certain instances, the therapeutic agent is a TNF? inhibitor for the treatment of a TNF?-mediated disease or disorder.

Abstract: An apparatus for preparing a beverage by delivering sanitized liquid within a package containing nutritional ingredients. The apparatus includes a package comprising a product compartment containing nutritional ingredients and a spout arranged for the supply of liquid inside the compartment. The apparatus also includes a machine comprising a control unit and a liquid supply and treatment unit. Methods of production and use thereof are also disclosed.

Abstract: The present disclosure provides an apparatus comprising an air circulating device, an allergen source comprising an allergen, and a housing. The housing can be collapsible, portable, disposable and configurable. The present disclosure also provides a method comprising positioning an allergen source comprising an allergen in a chamber, distributing at least a portion of the allergen from the allergen source within the chamber, and collecting at least a portion of the distributed allergen. In an embodiment, the level of the shed allergen can be used to measure the effectiveness of various measures implemented to reduce airborne Fel d1 that is emitted from soiled cat litter. In another embodiment, the allergen can be introduced at a desired level in the chamber, and the resultant symptoms of a subject (e.g. a human) within the chamber can be identified and correlated with the amount of allergen.

Abstract: The invention relates to a head assembly for a beverage preparation device for preparing a nutritional composition upon interaction of ingredients provided in a capsule with liquid supplied to the capsule, the assembly comprising capsule opening means (10) which are adapted to interact with an injection face of the capsule, the opening means comprising a liquid injection means (1) for injection of liquid into the capsule and a gas injection means (2) for injecting of gas into the capsule, activation means (20) designed for interacting with the opening means and for moving the liquid injection means and the gas injection means with respect to the injection face of the capsule. The head assembly also comprises a drive unit (70) for driving the activation means (20) and the activation means comprises a driving gear (20b) adapted to be driven in rotational movement by the drive unit (70) for sequentially moving the liquid injection means (1) and gas injection means (2).

Abstract: The invention relates to a reduced sugar powdered beverage composition.

Abstract: Process for the treatment of a sweet whey material (SWM) containing cGMP (caseinoGlycoMacroPeptide), comprising the following steps: Decationising the SWM material so as to obtain a sweet whey SW having a pH value of 1 to 4.5; Treating said SW in a fluidized bed reactor comprising a volume of an anionic resin, at 10 to 18° C., wherein said SW contacts said resin so that the resin absorbs between 0% and 100% of the cGMP present in the SW; and Recovering a protein material; Wherein the treating is such that the resin absorbs 30 to 45 g/L of the cGMP present in the sweet whey.